Company Overview of Cantex Pharmaceuticals, Inc.
Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops 2-O and 3-O desulfated heparin to ameliorate cardiac ischemia-reperfusion injury. It provides PGX-100, which reduces damage to the heart in animal models of myocardial infarction. The company was formerly known as ParinGenix, Inc. Cantex Pharmaceuticals, Inc. was incorporated in 2002 and is based in Weston, Florida.
1792 Bell Tower Lane
Weston, FL 33326
Founded in 2002
Key Executives for Cantex Pharmaceuticals, Inc.
Cantex Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Hawaii Biotech, Inc.||United States|
|Floratine BioSciences, Inc.||United States|
|Quanticel Pharmaceuticals, Inc.||United States|
|Cardioxyl Pharmaceuticals, Inc.||United States|
|Biomedica Management Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Santa Monica, CA | AstellasPosted: Mar 10
- Princeton, NJ | RGPPosted: Mar 05
- San Francisco, CA | PwCPosted: Apr 12
- Deerfield, IL | Takeda Pharmaceuticals North AmericaPosted: Feb 22
Sponsored Financial Commentaries
To contact Cantex Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.